Macy's Insider Sale Notice — 100,000 Shares Planned on 09/10/2025

Rhea-AI Filing Summary

Macy's, Inc. (M) Form 144 notifies the proposed sale of 100,000 shares of common stock to be executed through Charles Schwab on 09/10/2025 with an aggregate market value listed at $1,721,000.00 and 268,505,751 shares outstanding. The filing lists a series of restricted and performance-based stock vestings from 03/21/2024 through 03/31/2025 that together account for the securities to be sold, and indicates the shares were received as compensation. The seller is identified as Danielle L. Kirgan with a prior sale on 09/05/2025 of 100,000 shares generating gross proceeds of $1,729,527.03. The notice includes the signer’s representation that no undisclosed material adverse information is known.

Insights

Securities Analyst

TL;DR: Insider sale filing shows a planned disposal of 100,000 Macy's shares derived from vested compensation; prior near-term sale recorded.

The filing documents a Rule 144 notice for the proposed sale of 100,000 Macy's common shares, clearly attributing the shares to multiple restricted and performance vesting events between March 2024 and March 2025. The filing identifies the selling brokerage and shows a recent completed sale on 09/05/2025 of an identical lot size with disclosed proceeds. For investors, this is a routine insider liquidity event supported by documented vesting and compensation origin; it does not include forward-looking company operational data.

Compliance / Corporate Governance Expert

TL;DR: The Form 144 appears procedurally complete, listing acquisition dates, vesting origin, and a contemporaneous prior sale.

The notice supplies required Rule 144 details: acquisition dates, nature of acquisition (restricted/performance vesting), amounts, payment nature (compensation), broker name, planned sale date, and gross value. It also contains the standard attestation regarding material non-public information. The document lacks any indication of trading plan adoption or 10b5-1 specifics, but complies with disclosure fields present in the form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab 211 Main Street San Francisco CA 94105	100000	1721000.00	268505751	09/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/21/2024	Performance Restricted Stock Vesting	Macy's, Inc.			20394	03/21/2024	Compensation
Common Stock	03/24/2024	Restricted Stock Vesting	Macy's, Inc.			5265	03/24/2024	Compensation
Common Stock	03/25/2024	Restricted Stock Vesting	Macy's, Inc.			6631	03/25/2024	Compensation
Common Stock	03/31/2024	Restricted Stock Vesting	Macy's, Inc.			6184	03/31/2024	Compensation
Common Stock	07/09/2024	Restricted Stock Vesting	Macy's, Inc.			23365	07/09/2024	Compensation
Common Stock	03/24/2025	Restricted Stock Vesting	Macy's, Inc.			5421	03/24/2025	Compensation
Common Stock	03/25/2025	Restricted Stock Vesting	Macy's, Inc.			8646	03/25/2025	Compensation
Common Stock	03/27/2025	Performance Restricted Stock Vesting	Macy's, Inc.			8596	03/27/2025	Compensation
Common Stock	03/28/2025	Restricted Stock Vesting	Macy's, inc.			7156	03/28/2025	Compensation
Common Stock	03/31/2025	Restricted Stock Vesting	Macy's, Inc.			8342	03/31/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Danielle L. Kirgan c/o Macy's, Inc. 151 West 34th Street New York NY 10001	Common Stock	09/05/2025	100000	1729527.03

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Macy's (M) Form 144 filed for 09/10/2025 disclose?

The filing discloses a proposed sale of 100,000 common shares through Charles Schwab on 09/10/2025 with an aggregate market value of $1,721,000.00 and shows the shares stem from multiple restricted/performance stock vestings.

Who is the seller in the Macy's (M) Form 144 and what recent sales are reported?

The seller is identified as Danielle L. Kirgan. The filing also reports a sale on 09/05/2025 of 100,000 shares for gross proceeds of $1,729,527.03.

What is the origin of the shares listed in the Form 144 for Macy's (M)?

All listed shares were acquired via restricted stock vesting or performance restricted stock vesting from Macy's, Inc., with acquisition dates between 03/21/2024 and 03/31/2025.

Does the Form 144 indicate the nature of payment for the acquired shares?

Yes; the table indicates the nature of payment for the acquisitions is compensation.

Is there any disclosure of a 10b5-1 trading plan in the Form 144?

The filing does not provide a date or specific statement indicating adoption of a 10b5-1 trading plan.